Ferumoxytol + Gadobutrol
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
IC - Interstitial Cystitis
Conditions
IC - Interstitial Cystitis
Trial Timeline
Mar 29, 2023 → May 20, 2025
NCT ID
NCT05811377About Ferumoxytol + Gadobutrol
Ferumoxytol + Gadobutrol is a phase 1 stage product being developed by Lipella Pharmaceuticals for IC - Interstitial Cystitis. The current trial status is completed. This product is registered under clinical trial identifier NCT05811377. Target conditions include IC - Interstitial Cystitis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05811377 | Phase 1 | Completed |
Competing Products
20 competing products in IC - Interstitial Cystitis